Showing results (1911-1920 of 1,974) with videos related to
Sort By:
Pageof 198
Gut|November 6, 2025
Indole-3-propionic acid links gut dysfunction to diabetic retinopathy: a biomarker and novel therapeutic approachRam Prasad, Yvonne Adu-Rutledge, Borhane Ziani, et al.Annals of Emergency Medicine|June 3, 2014
Priorities for emergency department syncope researchBenjamin C Sun, Giorgio Costantino, Franca Barbic, et al.Journal of Pediatric Surgery|December 18, 2025
Opioid prescriptions practices following the minimally invasive repair of pectus excavatum: A western pediatric surgery research consortium studyAnastasia M Kahan, R Scott Eldredge, Lauren Nicassio, et al.Gynecologic Oncology|January 24, 2020
Low-grade serous ovarian cancer: State of the scienceBrian Slomovitz, Charlie Gourley, Mark S Carey, et al.Journal of Surgical Oncology|August 9, 2017
Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinomaKoji Matsuo, Kwong-Kwok Wong, Christina Fotopoulou, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2021
Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian CancerShannon N Westin, Marilyne Labrie, Jennifer K Litton, et al.Blood|October 15, 2021
Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host diseaseMelissa D Docampo, Marina B da Silva, Amina Lazrak, et al.Genome Research|May 29, 2010
Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genomeRussell C DeKelver, Vivian M Choi, Erica A Moehle, et al.JCI Insight|February 23, 2026
New approaches to uncover COPD pathobiology and develop therapiesYohannes Tesfaigzi, Ali Önder Yildirim, Francesca Polverino, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|September 2, 2020
[Efficacy analysis of the radiotherapy and chemotherapy in patients with stage Ⅳ esophageal squamous carcinoma: a multicenter retrospective study of Jing-Jin-Ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group (3JECROG R-01F)]M M Hu, Q Q Yuan, X S Zhang, et al.Pageof 198